BEIJING KAWIN TECHNOLOGY SHARE-HOLDING CO., LTD.

Beijing Kawin Technology Share-Holding Co., Ltd.

Equities

688687

CNE1000054C3

Biotechnology & Medical Research

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-05-16 pm EDT			5-day change	1st Jan Change
30.19 ^CNY	-0.30%		-0.89%	-13.40%

Apr. 10	China stocks down pressured by real estate; HK shares up	RE
Apr. 09	Beijing Kawin Technology Share-Holding Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Tranche Update on Beijing Kawin Technology Share-Holding Co., Ltd.'s Equity Buyback Plan announced on June 1, 2022.

October 10, 2022

From July 1, 2022 to September 30, 2022, the company has repurchased 2,418,820 shares, representing 1.42% for CNY 38.21 million. With this, the company has completed the repurchase of 2,568,820 shares, representing 1.5% for CNY 40.9 million under the buyback announced on June 1, 2022.

Latest news about Beijing Kawin Technology Share-Holding Co., Ltd.

China stocks down pressured by real estate; HK shares up	Apr. 10	RE
Beijing Kawin Technology Share-Holding Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 09	CI
Beijing Kawin Technology Share-Holding Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 23	CI
Beijing Kawin Technology Share-Holding Plans Share Private Placement to Fund Project, Replenish Capital	Feb. 02	CI
Beijing Kawin Technology Share-Holding Co., Ltd. announced that it expects to receive CNY 300 million in funding	Feb. 01	CI
Beijing Kawin Technology Share-Holding Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-26	CI
Beijing Kawin Technology Share-Holding Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-24	CI
Kawin Technology Gets Nod to Carry Out Trials Into Tumor Drug	23-07-24	MT
Beijing Kawin Technology Share-Holding Co., Ltd.'s Equity Buyback announced on June 1, 2022, has expired.	23-05-30	CI
Beijing Kawin Technology Share-Holding Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-21	CI
Beijing Kawin Technology Share-Holding Co., Ltd. announced that it expects to receive CNY 300 million in funding	23-04-20	CI
Tranche Update on Beijing Kawin Technology Share-Holding Co., Ltd.'s Equity Buyback Plan announced on June 1, 2022.	23-04-03	CI
Beijing Kawin Technology Share-Holding Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-22	CI
Beijing Kawin Technology Share-Holding Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-27	CI
Tranche Update on Beijing Kawin Technology Share-Holding Co., Ltd.'s Equity Buyback Plan announced on June 1, 2022.	22-10-10	CI
Beijing Kawin Technology Share-Holding Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-24	CI
Beijing Kawin Technology Share-Holding Co., Ltd. signed equity transfer agreement to acquire 16% stake in Beijing Yizhuang International Protein Drug Technology Co., Ltd from Zhoushan Herui Investment Partnership (Limited Partnership) for CNY 4 million.	22-08-01	CI
Tranche Update on Beijing Kawin Technology Share-Holding Co., Ltd.'s Equity Buyback Plan announced on June 1, 2022.	22-07-05	CI
Beijing Kawin Technology Share-Holding Co., Ltd. announces an Equity Buyback for CNY 120 million worth of its shares.	22-06-01	CI
Beijing Kawin Technology Share-Holding Co., Ltd. authorizes a Buyback Plan.	22-05-31	CI
Beijing Kawin Technology Share-Holding Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-20	CI
Beijing Kawin Technology Share-Holding Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-02-24	CI
Beijing Kawin Technology Share-Holding Co., Ltd.(SHSE:688687) added to Shanghai Stock Exchange Composite Index	22-02-24	CI
Beijing Kawin Technology Share-Holding Co., Ltd.(SHSE:688687) added to Shanghai Stock Exchange A Share Index	22-02-24	CI
ISR Holdings AB Enters into Collaboration Regarding Hepatitis B with Beijing Kawin Technology Share-Holding Co., Ltd	20-09-09	CI

Chart Beijing Kawin Technology Share-Holding Co., Ltd.

Duration

Period

Chart Beijing Kawin Technology Share-Holding Co., Ltd.

More charts

Company Profile

Beijing Kawin Technology Share-Holding Co Ltd is a China-based company principally engaged in the production and sales of therapeutic drugs in the viral disease field, and the research and development of innovative drugs. The Company's recombinant human interferon Î±2b and compound glycyrrhizin drugs are applied to treat viral diseases. The Company mainly distributes its products within domestic market.

Sector

Biotechnology & Medical Research

Calendar

2024-08-21 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Beijing Kawin Technology Share-Holding Co., Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

30.19 CNY

Average target price

39.66 CNY

Spread / Average Target

+31.36%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Bio Therapeutic Drugs

	1st Jan change	Capi.
BEIJING KAWIN TECHNOLOGY SHARE-HOLDING CO., LTD.	-13.40%	700M
VERTEX PHARMACEUTICALS INCORPORATED	+9.42%	115B
REGENERON PHARMACEUTICALS, INC.	+11.84%	106B
ARGENX SE	-1.05%	21.96B
BIONTECH SE	-14.15%	21.87B
GENMAB A/S	-5.29%	19.21B
BEIGENE, LTD.	-4.16%	18.08B
WUXI APPTEC CO., LTD.	-38.29%	17.71B
NEUROCRINE BIOSCIENCES, INC.	+7.99%	14.32B
SAREPTA THERAPEUTICS, INC.	+36.24%	12.42B

Bio Therapeutic Drugs